Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05018793 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Suspended to Recruitingv3 Show 6 more changesShow less
    • Primary and study completion dates: Dec 2025 to Dec 2028
    • Start date changed from estimate of Dec 2021 to Dec 1, 2024
    • Study sites: 1 to 2
    • Interventions: autologous adipose derived mesenchymal stem cells (Biological) to AlloRx (Biological), autologous adipose derived mesenchymal stem cells (Biological)
    • Study description expanded, about 9 words
    • Study title expanded, about 9 words
  2. Trial status: Recruiting to Suspended Sponsor's reason: Covid-19
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This trial will study the safety and efficacy of intrathecal injection of cultured autologous adult adipose derived mesenchymal stem cells versus cultured allogeneic adult umbilical-cord derived mesenchymal stem cells for the treatment of spinal cord injury
Trial Details
NCT Number NCT05018793
Lead Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Conditions
(from sponsor)		 Spinal Cord Injuries
Related terms Spinal Cord Injuries
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov